Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie: eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
2015
|
| In: |
Der Pathologe
Year: 2014, Jahrgang: 36, Heft: 1, Pages: 92-97 |
| ISSN: | 1432-1963 |
| DOI: | 10.1007/s00292-014-2069-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00292-014-2069-x
|
| Verfasserangaben: | E. Dahl, A. Jung, J. Fassunke, M. Hummel, R. Penzel, W. Dietmaier, S. Laßmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1556551398 | ||
| 003 | DE-627 | ||
| 005 | 20220813160606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170412r20152014xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00292-014-2069-x |2 doi | |
| 035 | |a (DE-627)1556551398 | ||
| 035 | |a (DE-576)486551393 | ||
| 035 | |a (DE-599)BSZ486551393 | ||
| 035 | |a (OCoLC)1340972901 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dahl, Edgar |e VerfasserIn |0 (DE-588)1081789182 |0 (DE-627)846666464 |0 (DE-576)454791232 |4 aut | |
| 245 | 1 | 0 | |a Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie |b eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP) |c E. Dahl, A. Jung, J. Fassunke, M. Hummel, R. Penzel, W. Dietmaier, S. Laßmann |
| 246 | 3 | 1 | |a Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP) |
| 264 | 1 | |c 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 24. Dezember 2014 | ||
| 500 | |a Gesehen am 12.04.2017 | ||
| 534 | |c 2014 | ||
| 700 | 1 | |a Penzel, Roland |e VerfasserIn |0 (DE-588)102044021X |0 (DE-627)691221316 |0 (DE-576)360421083 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Pathologe |d Berlin : Springer, 1994 |g 36(2015), 1, Seite 92-97 |h Online-Ressource |w (DE-627)25463866X |w (DE-600)1462980-X |w (DE-576)074531603 |x 1432-1963 |7 nnas |a Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP) |
| 773 | 1 | 8 | |g volume:36 |g year:2015 |g number:1 |g pages:92-97 |g extent:6 |a Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00292-014-2069-x |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170412 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 102044021X |a Penzel, Roland |m 102044021X:Penzel, Roland |d 910000 |d 912000 |e 910000PP102044021X |e 912000PP102044021X |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 999 | |a KXP-PPN1556551398 |e 2964968012 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie","subtitle":"eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)","title_sort":"Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie"}],"recId":"1556551398","titleTranslated":[{"translated":"Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["ger"],"name":{"displayForm":["E. Dahl, A. Jung, J. Fassunke, M. Hummel, R. Penzel, W. Dietmaier, S. Laßmann"]},"person":[{"family":"Dahl","roleDisplay":"VerfasserIn","given":"Edgar","display":"Dahl, Edgar","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Penzel","given":"Roland","role":"aut","display":"Penzel, Roland"}],"note":["Published online: 24. Dezember 2014","Gesehen am 12.04.2017"],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1556551398"],"doi":["10.1007/s00292-014-2069-x"]},"relHost":[{"disp":"Chancen und Risiken der blutbasierten molekularpathologischen Analytik zirkulierender Tumorzellen (CTC) und zellfreier DNA (cfDNA) in der personalisierten Krebstherapie eine Stellungnahme des Arbeitskreises „Liquid Biopsy“ der AG Molekularpathologie in der Deutschen Gesellschaft für Pathologie (DGP) = Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)Der Pathologe","title":[{"title_sort":"Pathologe","subtitle":"Organ der Deutschen Abteilung der Internationalen Akademie für Pathologie, der Deutschen, der Österreichischen und der Schweizerischen Gesellschaft für Pathologie und des Berufsverbandes Deutscher Pathologen","title":"Der Pathologe"}],"recId":"25463866X","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["ger","eng"],"pubHistory":["Volume 15, issue 1 (February 1994) [?]-volume 43, issue 3 (May 2022)"],"part":{"extent":"6","volume":"36","issue":"1","year":"2015","text":"36(2015), 1, Seite 92-97","pages":"92-97"},"note":["Gesehen am 05.07.2022","Teils ungezählte Beil.: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1432-1963"],"eki":["25463866X"],"zdb":["1462980-X"]},"origin":[{"dateIssuedDisp":"[1994?-2022]","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg ; New York"}]}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}]} | ||
| SRT | |a DAHLEDGARPCHANCENUND2015 | ||